Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: Results from the women's health initiative

Stroke

Volumn 41, Issue 5, 2010, Pages 857-862

  Rajpathak, Swapnil N ^a   Wang, Tao ^a   Wassertheil Smoller, Sylvia ^a   Strickler, Howard D ^a   Kaplan, Robert C ^a   McGinn, Aileen P ^a   Wildman, Rachel P ^a   Rosenbaum, Daniel ^b   Rohan, Thomas E ^a   Scherer, Philipp E ^c   Cushman, Mary ^d   Ho, Gloria Y F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SUNY Downstate Medical Center   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

Hepatocyte growth factor; Ischemic stroke; Women

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONSTEROID ANTIINFLAMMATORY AGENT; SCATTER FACTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GEOMETRY; HUMAN; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATOCYTE GROWTH FACTOR; HUMANS; INCIDENCE; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; WOMEN'S HEALTH;

EID: 77951768843     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.567719     Document Type: Article

References (35)

1. Zarnegar R, Michalopoulos G. Purification and biological characterization of human hepatopoietin a, a polypeptide growth factor for hepa-tocytes. Cancer Res. 1989;49:3314-3320. (Pubitemid 19162144)
2. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984;122:1450-1459. (Pubitemid 14073577)
3. Boros P, Miller CM. Hepatocyte growth factor: A multifunctional cyto-kine. Lancet. 1995;345:293-295.
4. Morishita R, Aoki M, Yo Y, Ogihara T. Hepatocyte growth factor as cardiovascular hormone: Role of hgf in the pathogenesis of cardiovascular disease. Endocrinol J. 2002;49:273-284. (Pubitemid 34832297)
5. Yamamoto Y, Kohara K, Tabara Y, Igase M, Nakura J, Miki T. Plasma hepatocyte growth factor and the relationship between risk factors and carotid atherosclerosis. Hypertens Res. 2002;25:661-667. (Pubitemid 35153752)
6. Satani K, Konya H, Hamaguchi T, Umehara A, Katsuno T, Ishikawa T, Kohri K, Hasegawa Y, Suehiro A, Kakishita E, Namba M. Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with type 2 diabetes. Diabet Med. 2006;23:617-622. (Pubitemid 43830061)
7. Kawamoto R, Oka Y, Yoshida O, Takagi Y. Significance of serum circulating hepatocyte growth factor in the development of carotid atherosclerosis. J Atheroscler Thromb. 2003;10:154-159.
8. Liu Y, Wilkinson FL, Kirton JP, Jeziorska M, Iizasa H, Sai Y, Nakashima E, Heagerty AM, Canfield AE, Alexander MY. Hepatocyte growth factor and c-met expression in pericytes: Implications for atherosclerotic plaque development. J Pathol. 2007;212:12-19. (Pubitemid 46746285)
9. Rehman J, Considine RV, Bovenkerk JE, Li J, Slavens CA, Jones RM, March KL. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol. 2003;41:1408-1413. (Pubitemid 36439005)
10. Nakamura S, Morishita R, Moriguchi A, Yo Y, Nakamura Y, Hayashi S, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Hepatocyte growth factor as a potential index of complication in diabetes mellitus. J Hypertens. 1998;16:2019-2026. (Pubitemid 29002383)
11. Hiratsuka A, Adachi H, Fujiura Y, Yamagishi S, Hirai Y, Enomoto M, Satoh A, Hino A, Furuki K, Imaizumi T. Strong association between serum hepa-tocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab. 2005;90:2927-2931. (Pubitemid 40686345)
12. Matsumori A, Takano H, Obata JE, Takeda S, Tsuyuguchi N, Ono K, Okada M, Miyamoto T, Ohnishi T, Daikuhara Y, Sasayama S. Circulating hepatocyte growth factor as a diagnostic marker of thrombus formation in patients with cerebral infarction. Circ J. 2002;66:216-218.
13. Anan F, Shimomura T, Imagawa M, Masaki T, Nawata T, Takahashi N, Yonemochi H, Eshima N, Saikawa T, Yoshimatsu H. Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis. Metabolism. 2007;56:593-598. (Pubitemid 46574721)
14. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, Rossouw JE. The women's health initiative recruitment methods and results. Ann Epidemiol. 2003;13:S18-S77. (Pubitemid 37324176)
15. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The women's health initiative observational study: Baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003;13:S107-S121 (Pubitemid 37324180)
16. The Women's Health Initiative Study Group. Design of the women's health initiative clinical trial and observational study. Control Clin Trials. 1998;19:61-109. (Pubitemid 28085557)
17. Kaplan RC, McGinn AP, Baird AE, Hendrix SL, Kooperberg C, Lynch J, Rosenbaum DM, Johnson KC, Strickler HD, Wassertheil-Smoller S. Inflammation and hemostasis biomarkers for predicting stroke in post-menopausal women: The women's health initiative observational study. J Stroke Cerebrovasc Dis. 2008;17:344-355.
18. Wassertheil-Smoller S, Kooperberg C, McGinn AP, Kaplan RC, Hsia J, Hendrix SL, Manson JE, Berger JS, Kuller LH, Allison MA, Baird AE. Lipoprotein-associated phospholipase a2, hormone use, and the risk of ischemic stroke in postmenopausal women. Hypertension. 2008;51: 1115-1122. (Pubitemid 351398957)
19. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35-41.
20. Luminex. Xmap technology. Available at: www.luminexcorp.com 2009.
21. Kaplan RC, Ho GY, Xue X, Rajpathak S, Cushman M, Rohan TE, Strickler HD, Scherer PE, Anastos K. Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev. 2007;16:1291-1293. (Pubitemid 46984974)
22. Haug C, Schmid-Kotsas A, Zorn U, Bachem MG, Schuett S, Gruenert A, Rozdzinski E. Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release. Am J Physiol Heart Circ Physiol. 2000;279:H2865-H2871. (Pubitemid 32005876)
23. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA. 2003;100: 4736-4741. (Pubitemid 36457799)
24. Beilmann M, Vande Woude GF, Dienes HP, Schirmacher P. Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood. 2000;95: 3964-3969. (Pubitemid 30412875)
25. Ma H, Calderon TM, Fallon JT, Berman JW. Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. Atherosclerosis. 2002;164:79-87. (Pubitemid 34765640)
26. Takiuchi S, Mannami T, Miyata T, Kamide K, Tanaka C, Kokubo Y, Koyama Y, Inamoto N, Katsuya T, Iwai N, Kawano Y, Ogihara T, Tomoike H. Identification of 21 single nucleotide polymorphisms in human hepatocyte growth factor gene and association with blood pressure and carotid atherosclerosis in the japanese population. Atherosclerosis. 2004;173:301-307. (Pubitemid 38469800)
27. Bell LN, Ward JL, Degawa-Yamauchi M, Bovenkerk JE, Jones R, Cacucci BM, Gupta CE, Sheridan C, Sheridan K, Shankar SS, Steinberg HO, March KL, Considine RV. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab. 2006;291:E843-E848. (Pubitemid 44484928)
28. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273-2282. (Pubitemid 38535056)
29. Rahimi N, Saulnier R, Nakamura T, Park M, Elliott B. Role of hepatocyte growth factor in breast cancer: A novel mitogenic factor secreted by adipocytes. DNA Cell Biol. 1994;13:1189-1197.
30. Vistoropsky Y, Trofimov S, Malkin I, Kobyliansky E, Livshits G. Genetic and environmental determinants of hepatocyte growth factor levels and their association with obesity and blood pressure. Ann Hum Biol. 2008; 35:93-103. (Pubitemid 351264503)
31. Anan F, Masaki T, Yonemochi H, Takahashi N, Nakagawa M, Eshima N, Saikawa T, Yoshimatsu H. Hepatocyte growth factor levels are associated with the results of 123i-metaiodobenzylguanidine myocardial scintigra-phy in patients with type 2 diabetes mellitus. Metabolism. 2009;58: 167-173.
32. Lieb W, Safa R, Benjamin EJ, Xanthakis V, Yin X, Sullivan LM, Larson MG, Smith HM, Vita JA, Mitchell GF, Sawyer DB, Vasan RS. Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. Eur Heart J. 2009;30:1121-1127.
33. Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension. 1996;28: 409-413. (Pubitemid 26296043)
34. Morishita R, Moriguchi A, Higaki J, Ogihara T. Hepatocyte growth factor (HGF) as a potential index of severity of hypertension. Hypertens Res. 1999;22:161-167. (Pubitemid 29450305)
35. Nakamura S, Moriguchi A, Morishita R, Aoki M, Yo Y, Hayashi S, Nakano N, Katsuya T, Nakata S, Takami S, Matsumoto K, Nakamura T, Higaki J, Ogihara T. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem Biophys Res Commun. 1998;242:238-243. (Pubitemid 28412409)